Proton Pump Inhibitor (PPI)
Pregnancy: Compatible — esomeprazole/omeprazole data reassuring throughout pregnancy.
Esomeprazole
Brand names: Nexium
Adult dose
Dose: GORD: 20–40mg OD for 4–8 weeks. Maintenance: 20mg OD. Peptic ulcer: 20–40mg OD. H. pylori eradication: 20mg BD (with antibiotics) × 7 days. Peptic ulcer bleeding (post-endoscopy): 80mg IV bolus then 8mg/hour infusion for 72 hours.
Route: Oral or IV
Frequency: Once daily (30 min before food)
Max: 40mg OD (standard); higher doses in Zollinger-Ellison syndrome under specialist care
S-isomer of omeprazole. IV preparation used post-endoscopic haemostasis for peptic ulcer bleeding (80mg bolus + 8mg/h × 72h). Oral absorption improved on empty stomach.
Paediatric dose
Route: Oral
Frequency: Once daily
Max: 40mg OD
BNF for Children: 1–11 years (≥10kg): body weight 10–<20kg: 10mg OD; ≥20kg: 10–20mg OD. 12–17 years: 20–40mg OD. Not licensed <1 year. Source: BNF for Children 2024.
Dose adjustments
Renal
No dose adjustment required.
Hepatic
Max 20mg OD in severe hepatic impairment (Child-Pugh C).
Clinical pearls
- IV esomeprazole post-endoscopy: 80mg bolus followed by 8mg/hour infusion for 72h significantly reduces re-bleeding after endoscopic haemostasis (HEAT study).
- S-isomer of omeprazole — marginally more potent acid suppression but clinically similar. Not preferred over pantoprazole with clopidogrel.
- Hypomagnesaemia: particularly relevant in patients on digoxin, diuretics, or at risk of QT prolongation — check Mg²⁺.
- Annual review of long-term PPI prescriptions — step down or stop when clinically appropriate.
Contraindications
- Concomitant atazanavir, nelfinavir, or rilpivirine
- Known hypersensitivity to proton pump inhibitors
Side effects
- Headache, abdominal pain, nausea, diarrhoea
- Hypomagnesaemia (long-term)
- C. difficile risk (long-term)
- Interstitial nephritis (rare)
- Osteoporosis / fracture risk (long-term high-dose use)
Interactions
- Clopidogrel: significant CYP2C19 inhibition — prefer pantoprazole
- Methotrexate: increased methotrexate levels — monitor
- Antiretrovirals (atazanavir, rilpivirine): significantly reduced absorption — avoid
- Warfarin: may increase INR
Monitoring
- Symptoms
- Mg²⁺ and B12 (long-term)
- INR if on warfarin
Reference: BNFc; BNF 90; NICE CG141 Peptic Ulcer; HEAT Study (Lancet 2016). Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- SMART Risk Score for Recurrent CVD · Cardiovascular Risk
- IABP Timing Assessment · Mechanical Circulatory Support
- PCSK9 Inhibitor Eligibility Assessment · Lipid Management
- Immune-Related Adverse Events (irAE) -- GI Toxicity Colitis Grading · Oncology-Related GI
- irAE Hepatitis Grading (CTCAE) · Immunotherapy
- DIPSS — Dynamic International Prognostic Scoring System for Myelofibrosis · Cancer Prognosis
Drugs
Pathways
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021